Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasms of Urinary Tract”

528 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 528 results

Not applicableStudy completedNCT00751140
What this trial is testing

Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection

Who this might be right for
Cancer of the Urinary Tract
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableLooking for participantsNCT06443268
What this trial is testing

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Who this might be right for
Quality of LifeStroke, AcuteSexual Behavior+7 more
University of Zurich 680
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Not applicableLooking for participantsNCT07416630
What this trial is testing

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Who this might be right for
Gynecologic CancerUrologic CancerBreast Cancer
Institute of Oncology Ljubljana 30
Not applicableEnded earlyNCT02818530
What this trial is testing

Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ultrasound

Who this might be right for
Urological CancerGastrointestinal CancerMalignant Female Reproductive System Neoplasm
Tata Memorial Centre 10
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63
Not applicableStudy completedNCT01215721
What this trial is testing

Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)

Who this might be right for
Urinary Incontinence
University of California, Irvine 40
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT03430895
What this trial is testing

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Who this might be right for
Non-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 535
Post-approval studies (Phase 4)Study completedNCT04502095
What this trial is testing

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Who this might be right for
Bladder CarcinomaRefractory Bladder CarcinomaUrinary Tract Infection
Roswell Park Cancer Institute 89
Not applicableWithdrawnNCT04583553
What this trial is testing

Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture

Who this might be right for
Urinary Tract InfectionsBladder Cancer
University of Kansas Medical Center
Not applicableUnknownNCT05063292
What this trial is testing

Effect of Prewarming On Skin Temperature Changes

Who this might be right for
Spinal AnesthesiaHypothermia Following AnesthesiaPrewarming+2 more
Bozyaka Training and Research Hospital 60
Not applicableUnknownNCT03628092
What this trial is testing

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Who this might be right for
Vulvovaginal AtrophyGenitourinary Symptoms and Ill-Defined Conditions
Royal North Shore Hospital 70
Not applicableUnknownNCT03787823
What this trial is testing

RCT-evaluation of Retzius-sparing Robotic Prostatectomy

Who this might be right for
Prostate CancerUrinary Incontinence
Heidelberg University 186
Very early researchUnknownNCT05180851
What this trial is testing

Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study

Who this might be right for
Head and Neck CancerMelanomaBreast Cancer+4 more
Shanghai Fengxian District Central Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Load More Results